Delivery Order SPE2DB25D3404-SPE2DB25FUPYY
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Eliquis 5 mg tablets (60-count units) valued at $13,624.62 on April 10, 2025, with completion scheduled for April 11, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026....
- The Defense Logistics Agency awarded a delivery order valued at $11,258.62 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages). The contract is a firm fixed price delivery order with an ultimate completion date of July 31, 2025, and was competitively awarded with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same municipality. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) valued at $11,416.41. This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a total value of $999,999,999.00 through December 2026. The work is to be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,965.60 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Eliquis 2.5 mg tablets (60-count units). This firm fixed-price contract, which is non-set-aside and competitively awarded, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a delivery order valued at approximately $60.3K to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on April 24, 2025, with an ultimate completion date of April 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The contract is fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a $13,969.73 delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Eliquis 5 mg tablets (60-count units). The contract, issued under firm fixed price terms with an ultimate completion date of June 2, 2025, represents a non-set-aside competitive award. This delivery order is executed as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a delivery order valued at $1,719.90 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on August 6, 2025, with completion scheduled for August 7, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the...
- The Defense Logistics Agency awarded a delivery order valued at $32,737.72 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on September 15, 2025, with an ultimate completion date of September 16, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child award under...
- The Defense Logistics Agency has awarded a delivery order valued at $123,658.99 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units). This competitively awarded, firm fixed-price delivery order, issued on August 18, 2025, with an ultimate completion date of August 19, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract contains no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Eliquis 5 mg tablets (60-count packaging) valued at $6,570.94 with a firm fixed price structure and a completion deadline of September 2, 2025. This non-set-aside competitive award represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime contract running through...
- SPE2DB25D3404Indefinite Delivery Contract
- SPE2DB25D3404-SPE2DB25FUPYYDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $34,348.79 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on August 20, 2025, with completion expected by August 21, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary pharmaceutical distribution operations. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal medical procurement vendor for military and veteran healthcare systems. As a prime vendor under the DLA Troop Support Medical contract, the company supplies a comprehensive range of pharmaceutical products including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This delivery order for Eliquis—a widely used anticoagulant medication—exemplifies the routine pharmaceutical procurement conducted through the company's established prime vendor vehicle, which enables efficient supply chain management for Defense Health Agency and other federal healthcare customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $34.3k | 8/20/25 |